MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BENNETT, L. L.
Right arrow Articles by HILL, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BENNETT, L. L., JR.
Right arrow Articles by HILL, D. L.

Molecular Pharmacology, Vol 11, 803-808, Copyright © 1975 by the American Society for Pharmacology and Experimental Therapeutics

Structural Requirements for Activity of Nucleosides as Substrates for Adenosine Kinase: Orientation of Substituents on the Pentofuranosyl Ring

L. LEE BENNETT JR. 1 and DONALD L. HILL 1

1 Kettering-Meyer Laboratory, Southern Research Institute, Birmingham, Alabama 35205

Selected nucleosides of adenine and 8-azaadenine were examined as substrates for adenosine kinase (EC 2.7.1.20), an enzyme that catalyzes the phosphorylation of many biologically active nucleosides, to evaluate the effects on substrate activity of various orientations of substituents on the pentofuranosyl ring. The enzyme used was partially purified from cultured H.Ep.2 cells. Although not all the possible isomers were studied, the results, together with other reported findings, lead to the conclusion that necessary, but not sufficient, conditions for substrate activity are the following: (a) the nucleoside should have a 2'-hydroxy group, (b) the 2'-hydroxy group should be trans to the purine moiety, and (c) there should exist a considerable degree of freedom of rotation about the C-1'—N-9 bond. If these conditions are met, the 3'-hydroxy group and the 4'-hydroxymethyl group may be either cis or trans to the purine ring. These results add to understanding of the mode of binding of substrates to adenosine kinase and should aid in the design of new nucleoside analogues as growth-inhibitory on antitumor agents.

Note:
ACKNOWLEDGMENTS We thank Dr. J. A. Montgomery, Dr. Y. F. Shealy, and Ms. H. J. Thomas for provision of compounds.

Submitted on February 27, 1975







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1975 by the American Society for Pharmacology and Experimental Therapeutics